These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 18381626)

  • 41. Comparative studies on inhibitors of HIV protease: a target for drug design.
    Jayaraman S; Shah K
    In Silico Biol; 2008; 8(5-6):427-47. PubMed ID: 19374129
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Crystal structure of lysine sulfonamide inhibitor reveals the displacement of the conserved flap water molecule in human immunodeficiency virus type 1 protease.
    Nalam MN; Peeters A; Jonckers TH; Dierynck I; Schiffer CA
    J Virol; 2007 Sep; 81(17):9512-8. PubMed ID: 17596316
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Improved prediction of HIV-1 protease-inhibitor binding energies by molecular dynamics simulations.
    Jenwitheesuk E; Samudrala R
    BMC Struct Biol; 2003 Apr; 3():2. PubMed ID: 12675950
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Binding pathways of ligands to HIV-1 protease: coarse-grained and atomistic simulations.
    Chang CE; Trylska J; Tozzini V; McCammon JA
    Chem Biol Drug Des; 2007 Jan; 69(1):5-13. PubMed ID: 17313452
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enzymatic and structural analysis of the I47A mutation contributing to the reduced susceptibility to HIV protease inhibitor lopinavir.
    Sasková KG; Kozísek M; Lepsík M; Brynda J; Rezácová P; Václavíková J; Kagan RM; Machala L; Konvalinka J
    Protein Sci; 2008 Sep; 17(9):1555-64. PubMed ID: 18560011
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition and substrate recognition--a computational approach applied to HIV protease.
    Vinkers HM; de Jonge MR; Daeyaert ED; Heeres J; Koymans LM; van Lenthe JH; Lewi PJ; Timmerman H; Janssen PA
    J Comput Aided Mol Des; 2003 Sep; 17(9):567-81. PubMed ID: 14713189
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Studies on adaptability of binding residues and flap region of TMC-114 resistance HIV-1 protease mutants.
    Purohit R; Rajendran V; Sethumadhavan R
    J Biomol Struct Dyn; 2011 Aug; 29(1):137-52. PubMed ID: 21696230
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Three-dimensional structure of a mutant HIV-1 protease displaying cross-resistance to all protease inhibitors in clinical trials.
    Chen Z; Li Y; Schock HB; Hall D; Chen E; Kuo LC
    J Biol Chem; 1995 Sep; 270(37):21433-6. PubMed ID: 7665551
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Multistage virtual screening and identification of novel HIV-1 protease inhibitors by integrating SVM, shape, pharmacophore and docking methods.
    Wei Y; Li J; Chen Z; Wang F; Huang W; Hong Z; Lin J
    Eur J Med Chem; 2015 Aug; 101():409-18. PubMed ID: 26185005
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Crucial roles of the subnanosecond local dynamics of the flap tips in the global conformational changes of HIV-1 protease.
    Li D; Ji B; Hwang K; Huang Y
    J Phys Chem B; 2010 Mar; 114(8):3060-9. PubMed ID: 20143801
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Restrained molecular dynamics simulations of HIV-1 protease: the first step in validating a new target for drug design.
    Perryman AL; Lin JH; McCammon JA
    Biopolymers; 2006 Jun; 82(3):272-84. PubMed ID: 16508951
    [TBL] [Abstract][Full Text] [Related]  

  • 52. X-ray structure of HIV-1 protease tethered dimer complexed to ritonavir.
    Das A; Rao DR; Hosur MV
    Protein Pept Lett; 2007; 14(6):565-8. PubMed ID: 17627597
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Flap opening and dimer-interface flexibility in the free and inhibitor-bound HIV protease, and their implications for function.
    Ishima R; Freedberg DI; Wang YX; Louis JM; Torchia DA
    Structure; 1999 Sep; 7(9):1047-55. PubMed ID: 10508781
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Small-molecule dimerization inhibitors of wild-type and mutant HIV protease: a focused library approach.
    Shultz MD; Ham YW; Lee SG; Davis DA; Brown C; Chmielewski J
    J Am Chem Soc; 2004 Aug; 126(32):9886-7. PubMed ID: 15303839
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A quantitative structure-activity relationship study for structurally diverse HIV-1 protease inhibitors: Contribution of conformational flexibility to inhibitory activity.
    Gohda K
    J Enzyme Inhib Med Chem; 2006 Oct; 21(5):609-15. PubMed ID: 17194035
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New active HIV-1 protease inhibitors derived from 3-hexanol: conformation study of the free inhibitors in crystalline state and in complex with the enzyme.
    Ziółkowska NE; Bujacz A; Randad RS; Erickson JW; Skálová T; Hašek J; Bujacz G
    Chem Biol Drug Des; 2012 May; 79(5):798-809. PubMed ID: 22296826
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relation between flexibility and positively selected HIV-1 protease mutants against inhibitors.
    Braz AS; Tufanetto P; Perahia D; Scott LP
    Proteins; 2012 Dec; 80(12):2680-91. PubMed ID: 22821809
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Design of novel HIV-1 protease inhibitors incorporating isophthalamide-derived P2-P3 ligands: Synthesis, biological evaluation and X-ray structural studies of inhibitor-HIV-1 protease complex.
    Ghosh AK; Brindisi M; Nyalapatla PR; Takayama J; Ella-Menye JR; Yashchuk S; Agniswamy J; Wang YF; Aoki M; Amano M; Weber IT; Mitsuya H
    Bioorg Med Chem; 2017 Oct; 25(19):5114-5127. PubMed ID: 28434781
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HIV-1 protease molecular dynamics of a wild-type and of the V82F/I84V mutant: possible contributions to drug resistance and a potential new target site for drugs.
    Perryman AL; Lin JH; McCammon JA
    Protein Sci; 2004 Apr; 13(4):1108-23. PubMed ID: 15044738
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Solution structure of HIV-1 protease flaps probed by comparison of molecular dynamics simulation ensembles and EPR experiments.
    Ding F; Layten M; Simmerling C
    J Am Chem Soc; 2008 Jun; 130(23):7184-5. PubMed ID: 18479129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.